Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Change in Acquisitions & Divestments: 2018-2025

Historic Change in Acquisitions & Divestments for Viridian Therapeutics, Inc.\DE (VRDN) over the last 6 years, with Sep 2025 value amounting to $140.3 million.

  • Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments fell 2.61% to $140.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $562.2 million, marking a year-over-year increase of 24.71%. This contributed to the annual value of $466.9 million for FY2024, which is 48.45% up from last year.
  • Latest data reveals that Viridian Therapeutics, Inc.\DE reported Change in Acquisitions & Divestments of $140.3 million as of Q3 2025, which was up 6.67% from $131.5 million recorded in Q2 2025.
  • Over the past 5 years, Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments peaked at $171.4 million during Q1 2025, and registered a low of -$497,000 during Q2 2021.
  • For the 3-year period, Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments averaged around $111.3 million, with its median value being $119.0 million (2024).
  • Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments surged by 3,276.95% in 2021 and then tumbled by 78.92% in 2022.
  • Viridian Therapeutics, Inc.\DE's Change in Acquisitions & Divestments (Quarterly) stood at $22.8 million in 2021, then spiked by 65.67% to $37.7 million in 2022, then soared by 172.76% to $102.8 million in 2023, then rose by 15.70% to $119.0 million in 2024, then decreased by 2.61% to $140.3 million in 2025.
  • Its Change in Acquisitions & Divestments stands at $140.3 million for Q3 2025, versus $131.5 million for Q2 2025 and $171.4 million for Q1 2025.